Antonio Silvani Selected Research

O-(6)-methylguanine

5/2007

Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Silvani Research Topics

Disease

20	Glioma (Gliomas) 03/2024 - 05/2003
20	Neoplasms (Cancer) 03/2024 - 05/2003
17	Glioblastoma (Glioblastoma Multiforme) 02/2024 - 05/2003
4	Pituitary Neoplasms (Pituitary Adenoma) 01/2024 - 06/2008
3	Prolactinoma (Prolactinomas) 01/2024 - 09/2018
3	Brain Neoplasms (Brain Tumor) 01/2022 - 04/2003
3	Disease Progression 05/2019 - 08/2009
3	Neoplasm Metastasis (Metastasis) 09/2009 - 06/2008
2	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 05/2003
2	Epilepsy (Aura) 01/2017 - 05/2016
2	Seizures (Absence Seizure) 09/2013 - 04/2008
2	Brain Diseases (Brain Disorder) 09/2013 - 09/2009
1	Pituitary Diseases (Disease, Anterior Pituitary) 01/2023
1	Meningioma (Meningiomas) 01/2022
1	Fatigue 01/2022
1	Ketosis 01/2021
1	Weight Loss (Weight Reduction) 01/2018
1	Parkinsonian Disorders (Parkinsonism) 05/2016
1	Nervous System Diseases (Neurological Disorders) 01/2016
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2016
1	Herpes Simplex Encephalitis (Herpes Encephalitis) 04/2015
1	Stroke (Strokes) 09/2013
1	Migraine Disorders (Migraine) 09/2013
1	Meningitis 01/2009
1	Breast Neoplasms (Breast Cancer) 06/2008
1	Thromboembolism 02/2006
1	Residual Neoplasm 04/2005
1	Germinoma 02/2005
1	Multiple Sclerosis 02/2004

Drug/Important Bio-Agent (IBA)

10	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 01/2004
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2012 - 05/2003
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 04/2008
3	Carmustine (FIVB)FDA Link 04/2013 - 08/2009
3	Mitoxantrone (Novantrone)FDA LinkGeneric 05/2008 - 04/2003
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2024 - 01/2022
2	EnzymesIBA 01/2024 - 04/2008
2	Cabergoline FDA LinkGeneric 01/2024 - 09/2018
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2024 - 01/2023
2	Conditioned Culture MediaIBA 03/2023 - 12/2013
2	Proteins (Proteins, Gene)FDA Link 03/2023 - 01/2004
2	Biomarkers (Surrogate Marker)IBA 03/2023 - 05/2012
2	fotemustine (Muphoran)IBA 01/2019 - 04/2008
2	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2009 - 05/2004
2	Plasminogen Activator Inhibitor 1IBA 02/2006 - 02/2004
2	Cisplatin (Platino)FDA LinkGeneric 02/2005 - 01/2004
1	vorasidenibIBA 01/2024
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2024
1	MicroRNAs (MicroRNA)IBA 03/2023
1	ProlactinIBA 01/2023
1	Chlorpromazine (Thorazine)FDA Link 01/2023
1	TrabectedinIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	KetonesIBA 01/2021
1	IDN 5109 (BAY 59-8862)IBA 05/2019
1	Valproic Acid (Depakote)FDA LinkGeneric 05/2016
1	AntibodiesIBA 01/2016
1	Antimitotic AgentsIBA 12/2015
1	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 11/2011
1	Bevacizumab (Avastin)FDA Link 11/2011
1	sagopiloneIBA 10/2009
1	Chemokine ReceptorsIBA 09/2009
1	Carcinoembryonic AntigenIBA 01/2009
1	Tumor Biomarkers (Tumor Markers)IBA 01/2009
1	Procarbazine (Matulane)FDA Link 04/2008
1	DNA (Deoxyribonucleic Acid)IBA 05/2007
1	MethyltransferasesIBA 05/2007
1	O-(6)-methylguanineIBA 05/2007
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 07/2006
1	thiamine triphosphorate (TTP)IBA 07/2006
1	CXCR ReceptorsIBA 07/2006
1	ChemokinesIBA 07/2006
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 07/2006
1	CoagulantsIBA 02/2006
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2005
1	Vinblastine (Vinblastine Sulfate)FDA Link 02/2005
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2004
1	Lipoprotein(a)IBA 02/2004
1	HomocysteineIBA 02/2004
1	fibrin fragment D (D-dimer)IBA 02/2004
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 01/2004
1	Antineoplastic Agents (Antineoplastics)IBA 01/2004
1	Interleukin-8 (Interleukin 8)IBA 05/2003
1	Interleukin-12 (IL 12)IBA 05/2003

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2018 - 02/2005
12	Radiotherapy 01/2024 - 02/2005
10	Therapeutics 03/2024 - 04/2008
3	Chemoradiotherapy 12/2015 - 11/2011
2	Palliative Care (Palliative Therapy) 07/2023 - 05/2023
2	Aftercare (After-Treatment) 02/2022 - 11/2021
2	Re-Irradiation 08/2015 - 06/2015
1	Adjuvant Chemotherapy 03/2024
1	Ketogenic Diet 01/2021
1	Combined Modality Therapy 09/2018
1	Transplantation 04/2015
1	Drug Tapering 08/2009
1	Radioimmunotherapy 04/2005
1	Immunotherapy 04/2005
1	Neoadjuvant Therapy 02/2005